Loading...
Loading...
Analysts at Bank of America initiated coverage on
Aduro BioTech IncADRO with a Buy rating.
The target price for Aduro BioTech is set to $40.
Aduro BioTech shares rose 1.46 percent to $31.30 in pre-market trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in